Constantine E. Kosmas

2.5k total citations · 2 hit papers
57 papers, 1.6k citations indexed

About

Constantine E. Kosmas is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Constantine E. Kosmas has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 27 papers in Cardiology and Cardiovascular Medicine and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Constantine E. Kosmas's work include Lipoproteins and Cardiovascular Health (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers) and Cancer, Lipids, and Metabolism (9 papers). Constantine E. Kosmas is often cited by papers focused on Lipoproteins and Cardiovascular Health (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers) and Cancer, Lipids, and Metabolism (9 papers). Constantine E. Kosmas collaborates with scholars based in United States, Greece and India. Constantine E. Kosmas's co-authors include Eliscer Guzman, Timothy J. Vittorio, Andreas Sourlas, Peter D. Montan, Delia Silverio, Christina Kostara, Raef Madanieh, Niel Shah, Harsh Patel and Hassan Alkhawam and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Current Medicinal Chemistry.

In The Last Decade

Constantine E. Kosmas

56 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin resistance and cardiovascular disease

2023 170 citations Constantine E. Kosmas, Christina Kostara et al. Journal of International Medical Research profile →
The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease

2023 126 citations Constantine E. Kosmas, E Papakonstantinou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Constantine E. Kosmas United States	23	533	501	422	258	254	57	1.6k
Shigemasa Tani Japan	24	592 1.1×	480 1.0×	309 0.7×	223 0.9×	223 0.9×	129	1.7k
Miao Wang China	22	406 0.8×	354 0.7×	283 0.7×	213 0.8×	186 0.7×	80	1.8k
Juan‐Carlos Kaski United Kingdom	18	493 0.9×	736 1.5×	289 0.7×	202 0.8×	266 1.0×	28	1.5k
Kohji Shirai Japan	23	453 0.8×	696 1.4×	359 0.9×	194 0.8×	316 1.2×	126	1.9k
Georgia Vogiatzi Greece	18	304 0.6×	504 1.0×	328 0.8×	293 1.1×	515 2.0×	83	2.0k
Xueying Li China	29	635 1.2×	537 1.1×	255 0.6×	206 0.8×	314 1.2×	165	2.5k
Sreenivasa Rao Kondapally Seshasai United Kingdom	12	588 1.1×	691 1.4×	1.0k 2.5×	305 1.2×	366 1.4×	21	2.2k
Michael Messig United States	23	831 1.6×	536 1.1×	629 1.5×	253 1.0×	156 0.6×	43	2.0k
Wenjun Fan United States	19	309 0.6×	492 1.0×	530 1.3×	260 1.0×	193 0.8×	59	1.4k
Sergio Martínez‐Hervás Spain	23	443 0.8×	225 0.4×	438 1.0×	290 1.1×	379 1.5×	117	1.6k

Countries citing papers authored by Constantine E. Kosmas

Since Specialization

Citations

This map shows the geographic impact of Constantine E. Kosmas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantine E. Kosmas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantine E. Kosmas more than expected).

Fields of papers citing papers by Constantine E. Kosmas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constantine E. Kosmas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantine E. Kosmas. The network helps show where Constantine E. Kosmas may publish in the future.

Co-authorship network of co-authors of Constantine E. Kosmas

This figure shows the co-authorship network connecting the top 25 collaborators of Constantine E. Kosmas. A scholar is included among the top collaborators of Constantine E. Kosmas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constantine E. Kosmas. Constantine E. Kosmas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kosmas, Constantine E., et al.. (2025). Novel RNA-Based Therapies in the Management of Dyslipidemias. International Journal of Molecular Sciences. 26(3). 1026–1026. 1 indexed citations

Giannopoulou, Eleni Z., et al.. (2024). Role of aspirin in the primary prevention of cardiovasculardisease in patients with hyperlipoproteinaemia(a). Drugs in Context. 13. 1–12. 2 indexed citations

Kosmas, Constantine E., et al.. (2023). Insulin resistance and cardiovascular disease. Journal of International Medical Research. 51(3). 3639225476–3639225476. 170 indexed citations breakdown →

Kosmas, Constantine E., et al.. (2023). PCSK9 Targeting in the Management of Hypercholesterolaemia. SHILAP Revista de lepidopterología. 87–97. 4 indexed citations

Kosmas, Constantine E., et al.. (2023). Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a). International Journal of Molecular Sciences. 24(17). 13622–13622. 19 indexed citations

Kosmas, Constantine E., et al.. (2021). New and emerging lipid-modifying drugs to lower LDL cholesterol. Drugs in Context. 10. 1–22. 24 indexed citations

Shah, Niel, et al.. (2020). Galectin-3 and soluble ST2 as complementary tools to cardiac MRI for sudden cardiac death risk stratification in heart failure: A review. SHILAP Revista de lepidopterología. 9. 405467792–405467792. 9 indexed citations

Kosmas, Constantine E., et al.. (2020). <p>Safety and Tolerability of PCSK9 Inhibitors: Current Insights</p>. Clinical Pharmacology Advances and Applications. Volume 12. 191–202. 28 indexed citations

Alkhawam, Hassan, et al.. (2019). An update on the CardioMEMS pulmonary artery pressure sensor. Therapeutic Advances in Cardiovascular Disease. 13. 335224714–335224714. 21 indexed citations

10.

Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, et al.. (2019). Anti-inflammatory therapy for cardiovascular disease. Annals of Translational Medicine. 7(7). 147–147. 49 indexed citations

11.

Montan, Peter D., et al.. (2019). Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Annals of Translational Medicine. 7(16). 393–393. 40 indexed citations

12.

Kosmas, Constantine E., et al.. (2018). Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia. Patient Preference and Adherence. Volume 12. 2263–2266. 25 indexed citations

13.

Kosmas, Constantine E., et al.. (2018). Primary genetic disorders affecting high density lipoprotein (HDL). Drugs in Context. 7. 1–11. 11 indexed citations

14.

Kosmas, Constantine E., et al.. (2017). Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy. Drugs in Context. 6. 1–7. 23 indexed citations

15.

Patel, Harsh, Hassan Alkhawam, Raef Madanieh, et al.. (2017). Aerobicvsanaerobic exercise training effects on the cardiovascular system. World Journal of Cardiology. 9(2). 134–134. 169 indexed citations

16.

Madanieh, Raef, et al.. (2015). A perspective on sympathetic renal denervation in chronic congestive heart failure. Heart Failure Reviews. 21(1). 1–10. 9 indexed citations

17.

Kosmas, Constantine E. & William H. Frishman. (2014). New and Emerging LDL Cholesterol–Lowering Drugs. American Journal of Therapeutics. 22(3). 234–241. 14 indexed citations

18.

Kosmas, Constantine E., et al.. (2014). High-Density Lipoprotein Functionality in Coronary Artery Disease. The American Journal of the Medical Sciences. 347(6). 504–508. 36 indexed citations

19.

Lanier, Gregg M., et al.. (2012). An Update on Diastolic Dysfunction. Cardiology in Review. 20(5). 230–236. 13 indexed citations

20.

Kosmas, Constantine E., et al.. (2012). Low‐Density Lipoprotein Levels in Patients With Acute Heart Failure. Congestive Heart Failure. 19(2). 85–91. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact